NRX Pharmaceuticals(DE:B1Q)
€2.02-0.11 (-5.40%)
DE:B1Q
NRX Pharmaceuticals earnings date
€2.02
At close:-0.11 (-5.40%)
NRX Pharmaceuticals (B1Q) Q2 2023 Earnings Report
1 Followers
DE:B1Q Q2 2023 EPS Results
- Actual EPS
- -EUR 1.09
- Consensus EPS
- -EUR 1.21
- Beat/Miss
- Beat by +EUR 0.12
- One Year Ago EPS
- -EUR 1.00
DE:B1Q Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/14/2023
- Time
- After Close
- Conference Call
- Monday, August 14, 2023
DE:B1Q Upcoming Earnings
NRX Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:B1Q Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:B1Q Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2026 | 2026 (Q3) | -0.19- | -0.24 | ― | ― |
| Aug 17, 2026 | 2026 (Q2) | -0.10-0.40 | -0.89 | 55.10% (+0.49) | |
| May 18, 2026 | 2026 (Q1) | 0.19-0.04 | -0.31 | 88.24% (+0.27) | |
| Mar 24, 2026 | 2025 (Q4) | 0.010.01 | -0.66 | 101.38% (+0.67) | |
| Nov 17, 2025 | 2025 (Q3) | -0.02-0.24 | -0.14 | -80.00% (-0.11) | |
| Aug 18, 2025 | 2025 (Q2) | -0.14-0.89 | -0.68 | -30.67% (-0.21) | |
| May 15, 2025 | 2025 (Q1) | -0.26-0.31 | -0.67 | 54.05% (+0.36) | |
| Mar 17, 2025 | 2024 (Q4) | -0.33-0.66 | -0.45 | -44.80% (-0.20) | |
| Nov 14, 2024 | 2024 (Q3) | -0.50-0.14 | -0.64 | 78.57% (+0.50) | |
| Aug 13, 2024 | 2024 (Q2) | -0.63-0.68 | -1.09 | 37.50% (+0.41) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

